A Novel Workflow to Create a Checkpoint Inhibitor Pneumonitis Patient Registry

Background Despite being a groundbreaking cancer therapy, immune checkpoint inhibitors (ICI) can lead to potentially life-threatening toxicity with checkpoint inhibitor pneumonitis (CIP). While treatable, it is easy for clinicians to miss the symptoms of CIP, which can lead to a delay in diagnosis a...

Descripción completa

Detalles Bibliográficos
Autores principales: Faucheux, Andrew, Olson, Eric, Lantz, Jeffrey, Roberts, Nathan, Aggarwal, Vanya, Newman, Indra, Ponnatapura, Janardhana, Lycan, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994379/
https://www.ncbi.nlm.nih.gov/pubmed/36909081
http://dx.doi.org/10.7759/cureus.34683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994379/
https://www.ncbi.nlm.nih.gov/pubmed/36909081
http://dx.doi.org/10.7759/cureus.34683

Ejemplares similares